Nebulized anti-IL-13 monoclonal antibody Fab' fragment reduces allergen-induced asthma.
about
Forkhead box protein A2 and T helper type 2-mediated pulmonary inflammationAligning mouse models of asthma to human endotypes of disease.Biologic comparison of inhaled insulin formulations: Exubera™ and novel spray-dried engineered particles of dextran-10.Glucagon Like Peptide-1 (GLP-1) Modulates OVA-Induced Airway Inflammation and Mucus Secretion Involving a Protein Kinase A (PKA)-Dependent Nuclear Factor-κB (NF-κB) Signaling Pathway in Mice.Intranasal exposure to monoclonal antibody Fab fragments to Japanese cedar pollen Cry j1 suppresses Japanese cedar pollen-induced allergic rhinitisIL-13 and STAT6 signaling involve in low dose lipopolysaccharide induced murine model of asthma.Antibody to FcεRIα Suppresses Immunoglobulin E Binding to High-Affinity Receptor I in Allergic Inflammation.A comparative study on the physicochemical and biological stability of IgG1 and monoclonal antibodies during spray drying processPredictors of asthma following severe respiratory syncytial virus (RSV) bronchiolitis in early childhood.IL-13 is a central mediator of chemical-induced airway hyperreactivity in mice.Optimizing the primary particle size distributions of pressurized metered dose inhalers by using inkjet spray drying for targeting desired regions of the lungs.Tomatidine Attenuates Airway Hyperresponsiveness and Inflammation by Suppressing Th2 Cytokines in a Mouse Model of Asthma.Fisetin-treatment alleviates airway inflammation through inhbition of MyD88/NF-κB signaling pathway.
P2860
Q26771725-25D809A1-F1EB-4616-8B67-8FA2CB4B0841Q33934140-9878728F-7E4F-4406-91B7-01DFE3B01169Q34577401-14A5F364-5791-4260-AE26-F2B4AAEC161FQ36183922-8AEDEC4A-E50C-468F-B00F-AB23F6FE82A0Q36830128-4563E60E-EAE3-4DA8-86D5-D151528CDF1DQ37077495-24AE9A90-D62F-40C8-9EB0-B6635D4AA403Q37231877-A78D3C7D-B3BF-4676-BAEA-B51F8159C5DDQ37679799-644CCE5B-C1A9-4308-A7F3-3CFB5605DD0AQ40766400-B08078C8-90B9-4009-991C-6CCE5B405AE7Q41007074-7A3F1AF9-248A-4DFB-87D8-4C817110AD24Q47199037-8EA2AB09-6D94-49C6-9150-99A15BC60491Q48130150-2DFCE8E1-73F0-47CE-9145-4739F4060699Q52641297-62A1A9C8-D33A-4AD3-9BD0-AD2B95E1A1D8
P2860
Nebulized anti-IL-13 monoclonal antibody Fab' fragment reduces allergen-induced asthma.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Nebulized anti-IL-13 monoclonal antibody Fab' fragment reduces allergen-induced asthma.
@en
Nebulized anti-IL-13 monoclonal antibody Fab' fragment reduces allergen-induced asthma.
@nl
type
label
Nebulized anti-IL-13 monoclonal antibody Fab' fragment reduces allergen-induced asthma.
@en
Nebulized anti-IL-13 monoclonal antibody Fab' fragment reduces allergen-induced asthma.
@nl
prefLabel
Nebulized anti-IL-13 monoclonal antibody Fab' fragment reduces allergen-induced asthma.
@en
Nebulized anti-IL-13 monoclonal antibody Fab' fragment reduces allergen-induced asthma.
@nl
P2093
P2860
P356
P1476
Nebulized anti-IL-13 monoclonal antibody Fab' fragment reduces allergen-induced asthma.
@en
P2093
Agnès Noel
Geneviève Paulissen
Jonathan Hacha
Kate Tomlinson
Ludovic Maertens
Maud Gueders
Natacha Rocks
Roger Palframan
P2860
P304
P356
10.1165/RCMB.2012-0031OC
P577
2012-08-16T00:00:00Z